(Hypertension. 2000;35:827.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
From the Department of Endocrinology, Malmö University Hospital MAS, Malmö, Sweden.
Correspondence to Dr Olle Melander, Department of Endocrinology, Malmö University Hospital MAS, S-205 02 Malmö, Sweden. E-mail Olle.Melander{at}endo.mas.lu.se
| Abstract |
|---|
|
|
|---|
Key Words: sodium insulin hypertension, genetic renin aldosterone glucose
| Introduction |
|---|
|
|
|---|
A large proportion of patients with primary hypertension are characterized by insulin resistance,3 4 which is suggested to be the cause of a cluster of cardiovascular risk factors called "the metabolic syndrome." In addition to disturbances in glucose metabolism and hypertension, this syndrome includes dyslipidemia, abdominal obesity, and microalbuminuria.5 Both salt sensitivity and insulin resistance are associated with a positive family history of hypertension6 7 8 and may therefore be part of the inherited predisposition to primary hypertension. Earlier studies have suggested that normotensive and hypertensive salt-sensitive subjects are hyperinsulinemic,9 10 insulin resistant,11 12 13 or both compared with salt-resistant subjects, suggesting that salt sensitivity and insulin sensitivity may be related. A change in salt intake may thus have different effects on insulin sensitivity in salt-sensitive compared with salt-resistant individuals. Studies on the effect of salt intake on serum insulin concentrations have provided conflicting results.9 10 14 15 16 However, serum insulin level is only a rough measure of insulin sensitivity.17 The influence of salt on insulin sensitivity has also been assessed through measurement of insulin sensitivity with the hyperinsulinemic euglycemic clamp18 or the insulin suppression test.19 High- compared with low-salt intake has been reported either to have no effect or to decrease insulin sensitivity in nondiabetic subjects.11 12 20 21 22 23 24 25 26 However, the effects of salt on insulin sensitivity were not analyzed with regard to the continuous distribution of salt sensitivity. Furthermore, varying cutoff points have been used in different studies to define salt sensitivity.11 12 20 With this notion, there is no consensus on whether a high-salt diet really influences insulin sensitivity. This information, however, may be very important for dietary guidelines for persons at risk for the metabolic syndrome and cardiovascular disease. Furthermore, studies on the interplay among dietary salt, salt sensitivity, the renin-angiotensin-aldosterone system (RAAS), and insulin sensitivity may help to provide new insights into the pathogenesis of primary hypertension. The present study was undertaken to investigate whether high-salt versus low-salt intake influences insulin sensitivity and whether salt sensitivity and insulin sensitivity are related in genetically hypertension-prone individuals.
| Methods |
|---|
|
|
|---|
Twenty-eight unrelated subjects (13 men and 15 women, mean age 48.6±6.6 years, body mass index 26.9±3.7 kg/m2) with at least 1 first-degree relative with primary hypertension were recruited from an ongoing collection of families with a high frequency of primary hypertension in the Scania region of southern Sweden. There was no significant difference between men and women with respect to age (46.7±6.0 versus 50.3±6.9 years, P=0.15) or body mass index (27.4±3.4 versus 26.4±3.9 kg/m2, P=0.52). None of the subjects received any medication or had ever received antihypertensive treatment, nor did they have diabetes mellitus, kidney disease, or any other chronic disease. All except 3 women were postmenopausal. The premenopausal women were examined while in the follicular phase of the menstrual cycle.
Procedures
All subjects were investigated at baseline and after 1 and 2
weeks. The subjects were requested not to change the level of physical
activity for
1 week before the start of the study and throughout the
entire study period. After the baseline investigation, the study
subjects were put on a low-salt diet (10 mmol sodium and 70
mmol potassium per day) for 1 week. During the second week, sodium
chloride capsules (230 mmol/d) were added to the diet to reach a
high-salt intake of 240 mmol/d. The diet was composed by a
dietitian, and the daily energy intake was adjusted according to body
weight and gender (8400 to 11 760 kJ). The study subjects received all
meals from a metabolic ward. Blood pressure was measured
with the subjects in the supine position after 30 minutes of rest at
4-minute intervals during 40 minutes with an automatic oscillometric
device (DINAMAP 1846 SX; Critikon), and the mean value of the 10
measurements was used. The difference in mean arterial
blood pressure (the diastolic blood pressure plus one third
of the pulse pressure) after the high-salt diet compared with that
after the low-salt diet was defined as the degree of salt sensitivity.
Because salt sensitivity is normally distributed in the
population,1 and cutoff points for dichotomization of the
trait are arbitrary and differ among studies, we regarded salt
sensitivity as a continuous variable. After the blood pressure
measurements, fasting blood samples were drawn with the patients in the
supine position. Urine samples (24-hour samples) were collected before
the baseline investigation and at the end of the high- and low-salt
diet weeks. Insulin sensitivity was measured with a 2-hour
hyperinsulinemic euglycemic
clamp18 at the end of the 2 diet periods. Insulin
(Actrapid; Novo Nordisk) was infused with an infusion pump (Perfusor
Secura FT; Braun) at a rate of 45 mU/m2 body
surface area per minute. Blood glucose was analyzed every 5
minutes, and a constant infusion of a 20% glucose solution was
adjusted to keep blood glucose constant at 5.0 mmol/L. The glucose
disposal rate was calculated as the total amount of glucose infused
during the second hour of the clamp (in µmol ·
kg-1 · min-1).
Biochemical Assays
Serum and urine concentrations of sodium and potassium were
measured with standard biochemical methods. The serum insulin
concentrations were measured with a specific ELISA (DAKO), and free
fatty acids were measured with an enzymatic
colorimetric method (Wako Chemicals). Plasma renin
activity (PRA) and plasma aldosterone concentrations (PAC)
were measured with RIA diagnostic kits (Abbott
Laboratories), and urinary catecholamines were measured
with a fluorimetric method.27
Statistical Analysis
An NCSS statistical software (version 6.0.21; Statistical
Solutions Limited) was used for the statistical analyses. Data
are expressed as mean±SD. Differences between groupwise and paired
variables were compared with the use of unpaired and paired
t tests or with Mann-Whitney and Wilcoxons paired
rank tests, where appropriate. Relationships among salt sensitivity,
PRA, PAC, and metabolic variables were determined with
Pearsons correlation coefficient if the residuals were normally
distributed and with Spearmans correlations otherwise. All
probability values were calculated with 2-sided tests, and a level of
<0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
|
Body weight at baseline was related to insulin sensitivity only after the low-salt diet (r=-0.49, P=0.008), whereas body mass index at baseline was inversely related to insulin sensitivity after both the low- (r=-0.62, P=0.0005) and the high-(r=-0.51, P=0.006) salt diets. Neither body weight, body mass index, nor mean blood pressure at baseline was related to salt sensitivity or to the salt-induced change in insulin sensitivity (data not shown). Fasting insulin and blood glucose concentrations decreased after the high-salt diet compared with the low-salt diet, but the glucose disposal rate was not significantly changed in the group as a whole (Table). The glucose disposal rate was not related to the degree of salt sensitivity after either the low- (r=0.009, P=0.96) or the high- (r=0.21, P=0.27) salt diet.
In men, the high-salt intake induced a change in glucose disposal rate that was closely correlated with the degree of salt sensitivity (r=0.83, P=0.0004) (ie, the more salt sensitive the men were, the more improved was insulin sensitivity, whereas all of the salt-resistant men [those in whom mean arterial blood pressure decreased from the low- to the high-salt diet] had an impaired insulin sensitivity; Figure 1A). In the women, no such relationship was seen (r=0.18, P=0.53). The change in glucose disposal rate induced by the high-salt diet in men was strongly inversely related to the baseline PRA (r=-0.82, P=0.0006) (Figure 1B) and PAC (r=-0.87, P=0.00009) (Figure 1C) in the men, whereas this was not seen in women (r=-0.14, P=0.62; r=0.09, P=0.76, respectively). In men, salt sensitivity correlated inversely with PRA at baseline (r=-0.61, P=0.03), with PRA after the low-salt diet (r=-0.88, P=0.00006), and with the reduction in PRA from low- to high-salt intake (r=-0.86, P=0.0002). No such correlations were seen in the women (r=-0.35, P=0.20; r=-0.33, P=0.24; r=-0.27, P=0.33; respectively). Consequently, in the men, salt sensitivity was inversely related to PAC at baseline (r=-0.74, P=0.004), to PAC after low-salt intake (r=-0.63, P=0.02), and to the reduction in PAC from low- to high-salt intake (r=-0.59, P=0.03). Again, no such relations could be found in the women (r=0.24, P=0.38; r=-0.06, P=0.83; r=-0.01, P=0.97; respectively). In the women, salt sensitivity was directly correlated with the salt-induced increase in body weight (r=0.68, P=0.005). This relationship was not observed in the men (r=0.23, P=0.44). The salt-induced increase in body weight was not significantly related to the change in insulin sensitivity from low- to high-salt intake in either gender (r=0.30, P=0.28 for women; r=0.48, P=0.09 for men). The difference in urinary norepinephrine excretion after high-salt intake compared with low-salt intake (Table) was not related to the difference in insulin sensitivity between the same time points in either men (r=0.09, P=0.77) or women (r=-0.32, P=0.24).
|
| Discussion |
|---|
|
|
|---|
In contrast to the men, salt sensitivity in the women was directly related to body weight gain after salt loading and not to the activity of RAAS. This suggests that the mechanisms leading to salt sensitivity are different in men and women and may explain why the relationship between salt-induced changes in insulin sensitivity and salt sensitivity was restricted to men. No differences existed in age or body mass index between men and women. Furthermore, because the majority of women were postmenopausal, differences in estrogen status are unlikely to explain the gender differences.
The finding of raised urinary norepinephrine excretion or plasma norepinephrine concentrations after salt restriction compared with after salt loading has been described in several earlier studies,25 28 suggesting activation of the sympathetic nervous system by the relative hypovolemia induced with salt restriction.
Previous studies that investigated the effect of salt on insulin sensitivity measured with the hyperinsulinemic euglycemic clamp or the insulin suppression test in nondiabetics found either no effect or an impairment of insulin sensitivity after 4 to 7 days of salt loading compared with salt restriction.11 12 20 21 22 23 24 25 26 However, these reports did not relate the change in insulin sensitivity to the continuous distribution of salt sensitivity. In 1 study with mainly salt-resistant men (normotensive with no family history of hypertension), impaired insulin sensitivity was seen after high-salt intake.23 This is in accordance with the results in our male subjects, although we did not observe any relation between the change in free fatty acids and change in insulin sensitivity after the different salt diets (r=0.16, P=0.61), as reported in the previous study.23 Three studies used different cutoff levels for salt sensitivity and compared the effect of salt on insulin sensitivity between salt-sensitive and salt-resistant subjects.11 12 20 In 2 studies, no change in insulin sensitivity was seen,11 20 whereas in a recent study by Fuenmayor et al,12 insulin sensitivity was impaired after high-salt intake in salt-sensitive subjects. This is clearly at variance with our findings; there may be several possible explanations for this discrepancy. Earlier studies that dichotomized salt sensitivity used different cutoff levels,11 12 20 and the definition of the trait is therefore rather arbitrary. Instead, we chose to regard salt sensitivity as a continuous variable. This has the advantage of no assumptions and also allowed us to use the quantitative information. Genetic and environmental differences between the populations studied may also influence the results, as well as differences between the salt doses used and the methods used to measure insulin sensitivity. Our study also suggests gender-specific effects of salt loading on insulin sensitivity, and the gender distribution was not reported in the study by Fuenmayor et al.12
The association between salt sensitivity and suppression of RAAS activity is described in several earlier studies.1 29 30 We also observed a close relationship between the salt-induced change in insulin sensitivity in men and PRA (Figure, 1B) and PAC (Figure, 1C) at baseline. These data suggest that different baseline activities of RAAS contribute to the varying effects of salt intake on insulin sensitivity in salt-sensitive and salt-resistant men. Evidence is emerging suggesting a cross-talk between RAAS and the insulin signaling system.31 Angiotensin II (Ang II) has gluconeogenic and glycogenolytic properties in hepatocytes,32 33 and it inhibits insulin signaling in both heart muscle and aortic smooth muscle.31 34 These effects could be blocked by Ang II receptor antagonists.31 34 Both salt itself and RAAS activity have been shown to influence the expression of the Ang II receptor type 1 (AT1); high-salt and low-RAAS activity upregulate and low-salt and high-RAAS activity downregulate AT1 expression.35 36 37 38 39 The suppression of RAAS at baseline that we observed in salt-sensitive men was gradually alleviated with increasing salt resistance. Salt-sensitive men may therefore overexpress AT1, whereas salt-resistant men may show relatively low AT1 expression at baseline. Salt restriction activates RAAS in all subjects, leading to increased Ang II levels. This increase could theoretically lead to exaggerated effects in the salt-sensitive men due to AT1 overexpression at baseline, possibly including insulin resistance.31 32 33 34 In contrast, the suppression of RAAS and Ang II after salt loading may remove this inhibitory effect of Ang II on insulin sensitivity, which is observed as an improvement in insulin sensitivity in salt-sensitive men when changing from a low- to a high-salt intake. However, this hypothesis includes the assumption that downregulation of AT1 after 1 week of salt restriction is not able to fully compensate for the postulated AT1 overexpression at baseline in salt-sensitive men. Indeed, changes in salt concentrations have been shown to influence AT1 expression after 24 hours in vitro.38 On the other hand, the in vivo changes in AT1 expression in humans after changes in salt balance may be slower than those in vitro and could also be attenuated by other systems. Importantly, the low basal PRA and PAC values in salt-sensitive men reflect chronic RAAS suppression and AT1 overexpression. It could therefore be speculated that AT1 expression in salt-sensitive men is resistant to acute changes in salt intake and RAAS activity. In salt-resistant men, insulin sensitivity would be relatively resistant to changes in RAAS activity because they may have a lower expression of AT1 at baseline because of the high activity of RAAS.
In conclusion, the effect of salt intake on insulin sensitivity depends on the degree of salt sensitivity in genetically hypertension-prone men. With high- versus low-salt intake, insulin sensitivity gradually improved with the increased degree of salt sensitivity and decreased RAAS activity. This suggests an interaction among salt intake, salt sensitivity, RAAS, and insulin action in men.
| Acknowledgments |
|---|
Received June 30, 1999; first decision July 14, 1999; accepted October 29, 1999.
| References |
|---|
|
|
|---|
2.
Weinberger MH, Fineberg NS. Sodium and volume
sensitivity of blood pressure: age and pressure change over time.
Hypertension. 1991;18:6771.
3.
Shen DC, Shieh SM, Fuh MM, Wu DA, Chen YD, Reaven GM.
Resistance to insulin-stimulated-glucose uptake in patients with
hypertension. J Clin Endocrinol Metab. 1988;66:580583.
4. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350357.[Abstract]
5. Alberti KGMM, Zimmet PZ. Definition, diagnosis, and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus. provisional report of a WHO consultation. Diabetic Med. 1998;15:539553.[Medline] [Order article via Infotrieve]
6. Sharma AM, Schorr U. Salt sensitivity and insulin resistance: is there a link? Blood Press Suppl. 1996;1:5963.[Medline] [Order article via Infotrieve]
7. Skrabal F, Hamberger L, Ledochowski M. Inherited salt sensitivity in normotensive humans as a cause of essential hypertension: a new concept. J Cardiovasc Pharmacol. 1984;6:S215S223.
8. Endre T, Mattiasson I, Hulthen UL, Lindgarde F, Berglund G. Insulin resistance is coupled to low physical fitness in normotensive men with a family history of hypertension. J Hypertens. 1994;12:8188.[Medline] [Order article via Infotrieve]
9. Zavaroni I, Coruzzi P, Bonini L, Mossini GL, Musiari L, Gasparini V, Fantuzzi M, Reaven GM. Association between salt sensitivity and insulin concentrations in patients with hypertension. Am J Hypertens. 1995;8:855858.[Medline] [Order article via Infotrieve]
10. Sharma AM, Ruland K, Spies KP, Distler A. Salt sensitivity in young normotensive subjects is associated with a hyperinsulinemic response to oral glucose. J Hypertens. 1991;9:329335.[Medline] [Order article via Infotrieve]
11.
Sharma AM, Schorr U, Distler A. Insulin resistance in
young salt-sensitive normotensive subjects. Hypertension. 1993;21:273279.
12. Fuenmayor N, Moreira E, Cubeddu LX. Salt sensitivity is associated with insulin resistance in essential hypertension. Am J Hypertens. 1998;4:397402.
13. Galletti F, Strazzullo P, Ferrara I, Annuzzi G, Rivellese AA, Gatto S, Mancini M. NaCl sensitivity of essential hypertensive patients is related to insulin resistance. J Hypertens. 1997;15:14851491.[Medline] [Order article via Infotrieve]
14. Iwaoka T, Umeda T, Ohno M, Inoue J, Naomi S, Sato T, Kawakami I. The effect of low and high NaCl diets on oral glucose tolerance. Klin Wochenschr. 1988;66:724728.[Medline] [Order article via Infotrieve]
15. Egan BM, Weder AB, Petrin J, Hoffman RG. Neurohumoral and metabolic effects of short term dietary NaCl restriction in men. Am J Hypertens. 1991;4:416421.[Medline] [Order article via Infotrieve]
16. Egan BM, Stepniakowski K, Goodfriend TL. Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factor clustering. Am J Hypertens. 1994;7:886893.[Medline] [Order article via Infotrieve]
17. Ferrannini E, Mari A. How to measure insulin sensitivity. J Hypertens. 1998;16:895906.[Medline] [Order article via Infotrieve]
18.
DeFronzo RA, Tobin JD, Andreas R. Glucose clamp
technique: a method for quantifying insulin secretion and resistance.
Am J Physiol. 1979;237:E214E223.
19. Harano Y, Hidaka H, Takatsuki K, Ohgaku S, Haneda M, Motoi S, Kawagoe K, Shigeta Y, Abe H. Glucose, insulin, and somatostatin infusion for the determination of insulin sensitivity in vivo. Metabolism. 1978;27:S1449S1452.
20. Gruska S, Wolf E, Jendral I, Wedler B, Kraatz G. Salt sensitivity and insulin resistance in normotensives. Exp Clin Endocrinol Diabetes. 1997;105(suppl 2):2226.
21. Lind L, Lithell H, Gustafsson IB, Pollare T, Ljunghall S. Metabolic cardiovascular risk factors and sodium sensitivity in hypertensive subjects. Am J Hypertens. 1992;5:502505.[Medline] [Order article via Infotrieve]
22. Gaboury CL, Simonson DC, Seely EW, Hollenberg NK, Williams GH. Relation of pressor responsiveness to angiotensin II and insulin resistance in hypertension. J Clin Invest. 1994;94:22952300.
23.
Donovan DS, Solomon CG, Seely EW, Williams GH, Simonson
DC. Effect of sodium intake on insulin sensitivity. Am J
Physiol. 1993;264:E730E734.
24. Fliser D, Fode P, Arnold U, Nowicki M, Kohl B, Ritz E. The effect of dietary salt on insulin sensitivity. Eur J Clin Invest. 1995;25:3943.[Medline] [Order article via Infotrieve]
25. Foo M, Denver AE, Coppack SW, Yudkin JS. Effect of salt-loading on blood pressure, insulin sensitivity and limb flow in normal subjects. Clin Sci. 1998;95:157164.[Medline] [Order article via Infotrieve]
26.
Facchini FS, DoNascimento C, Reaven GM, Yip JW, Ni XP,
Humphreys MH. Blood pressure, sodium intake, insulin resistance, and
urinary nitrate excretion. Hypertension. 1999;33:10081012.
27. van der Hoorn FAJ, Boomsma F, Man Int Veld AJ, Schalekamp MADH. Improved measurement of urinary catecholamines by liquid-liquid extraction, derivatization and high performance liquid chromatography with fluorimetric detection. J Chromatogr. 1991;563:348355.[Medline] [Order article via Infotrieve]
28.
Graudal NA, Galloe AM, Garred P. Effects of sodium
restriction on blood pressure, renin, aldosterone,
catecholamines, cholesterols, and
triglyceride: a meta-analysis. JAMA. 1998;279:13831391.
29. Koolen MI, Bussemaker-Verduyn E, den Boer E, van Brummelen P. Clinical, biochemical and haemodynamic correlates of sodium sensitivity in essential hypertension. J Hypertens. 1983;1:S21S23.
30. Ishibashi K, Oshima T, Matsuura H, Watanabe M, Ishida M, Ishida T, Ozono R, Kajiyama G, Kanbe M. Effects of age and sex on sodium chloride sensitivity: association with plasma renin activity. Clin Nephrol. 1994;42:376380.[Medline] [Order article via Infotrieve]
31.
Velloso LA, Folli F, Sun X, White MF, Saad MJA, Kahn
CR. Cross-talk between the insulin and angiotensin
signaling systems. Proc Natl Acad Sci U S A. 1996;93:1249012495.
32. DeWitt LM, Putney JW. Stimulation of glycogenolysis in hepatocytes by angiotensin II may involve both calcium release and calcium influx. FEBS Lett. 1983;160:259263.[Medline] [Order article via Infotrieve]
33. Kneer NM, Lardy HA. Regulation of gluconeogenesis by norepinephrine, vasopressin, and angiotensin II: a comparative study in the absence and presence of extracellular calcium. Arch Biochem Biophys. 1983;225:187195.[Medline] [Order article via Infotrieve]
34. Folli F, Kahn CR, Hansen H, Bouchie JL, Feener EP. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. J Clin Invest. 1997;100:21582169.[Medline] [Order article via Infotrieve]
35. Nickenig G, Murphy TJ. Enhanced angiotensin receptor type 1 mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells. Mol Pharmacol. 1996;50:743751.[Abstract]
36. Lassegue B, Alexander RW, Nickenig G, Clark M, Murphy TJ, Griendling KK. Angiotensin II down regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation. Mol Pharmacol. 1995;48:601609.[Abstract]
37. Griendling KK, Lassegue B, Murphy TJ, Alexander RW. Angiotensin II receptor pharmacology. Adv Pharmacol. 1994;28:269306.
38.
Nickenig G, Strehlow K, Roeling J, Zolk O, Knorr A,
Böhm M. Salt induces vascular AT1 receptor overexpression in
vitro and in vivo. Hypertension. 1998;31:12721277.
39.
Aguilera G, Catt K. Regulation of vascular
angiotensin II receptors in the rat during altered sodium
intake. Circ Res. 1981;49:751758.
This article has been cited by other articles:
![]() |
M. N. Kerstens, F. G. H. van der Kleij, A. H. Boonstra, W. J. Sluiter, J. Koerts, G. Navis, and R. P. F. Dullaart Salt Loading Affects Cortisol Metabolism in Normotensive Subjects: Relationships with Salt Sensitivity J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4180 - 4185. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Melander, E. Frandsen, L. Groop, and U. L. Hulthen Plasma ProANP1-30 Reflects Salt Sensitivity in Subjects With Heredity for Hypertension Hypertension, May 1, 2002; 39(5): 996 - 999. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |